Community/Retail

The California wildfires caused many medical and community challenges, including triaging services, addressing basic needs, and supporting displaced residents.

The Justice Department alleges that Walgreens acted in violation of the Controlled Substances Act and sought reimbursement for unlawful prescriptions, violating the False Claims Act.

Increased technician involvement also improves patient care nationwide.

The report from the Office of Inspector General highlights inconsistencies, lack of transparency, and the need for stronger safeguards.

If finalized, the requirement would include readily available nutrition information, including saturated fat, sodium, and added sugar content.

Pharmacies are increasingly viewed as wellness hubs and community health partners.

Despite the reductions in hepatitis B surface antigen (HBsAg), grade 3 and 4 adverse events were not uncommon.

Pharmacies are actively working to address issues and support their patients by collaborative with regulatory bodies like the Board of Pharmacy, and their engagement with the local community.

As per the Inflation Reduction Act, the negotiations with the drug companies of the 15 drugs will occur in 2025, with the negotiated prices going into effect in 2027.

Hormonal contraceptives did not increase breast cancer risk in patients with BRCA2 mutations.

The current approved dose of axatilimab-csfr is 0.3 mg/kg up to a maximum dose of 35 mg and will be administered as an intravenous infusion over 30 minutes every 2 weeks.

This is mirikizumab’s second FDA-approved indication in inflammatory bowel disease.

Rite Aid survey highlights underutilized role of pharmacists in health care, with 62% of respondents viewing their pharmacists as a crucial part of their health and wellness care team.

A politically and economically stressed system of health care delivery and benefits is manifesting in the pharmacy benefit management sector.

Pharmacists help patients manage allergies and asthma by identifying triggers, recommending appropriate treatments, ensuring proper medication usage, and finding affordable options.

The finding could help better treat patients with long COVID, as pharmacists and treatment providers can look out for ME/CFS symptoms.

The test meets a critical unmet need for patients with Alzheimer disease who have not yet been undiagnosed.

Studies shows that Red Dye No. 3 was associated with tumor growth in male rats.

Jim Dente of Advanced Pharmacy Solutions emphasizes the growing role of automation, artificial intelligence, and patient-centric business models in streamlining operations, improving patient care, and addressing industry challenges such as staff burnout and medication errors.

mRNA-1345 (mRESVIA; Moderna) has the potential to significantly transform the RSV disease state in 2025, according to data analysts.

Posttraumatic stress disorder is found to be associated with coronary artery disease, hypertension, and heart failure.

The findings suggest that patients with alopecia areata (AA) who also have asthma may benefit from increased clinical monitoring and earlier intervention.

These drugs are set to revolutionize their respective disease states in 2025.

The pharmaceutical industry is facing a critical talent shortage caused by fewer students entering the field, burnout and a lack of stability. We offer ways to combat the shortage.

Patients with rheumatoid arthritis and higher body mass index (BMI) showed poorer clinical response to non-tumor necrosis factor (TNF)-targeted treatments.

Wildfire smoke carries toxic compounds that can trigger respiratory inflammation and cause cellular damage.

Pharmacists should prioritize the needs of the patient in front of them and determine what matters most in each specific situation.

Women living in rural are more likely to report experiencing psychological and somatic menopause symptoms compared with those in urban and suburban areas.

Dyslipidemia is a condition in which there are abnormal levels of lipids in the blood stream, including high levels of low-density lipoprotein cholesterol, low levels of high-density lipoprotein cholesterol, and/or high levels of triglycerides.

The new Medicare cap limits out-of-pocket drug costs to $2000 annually.